Valuation : Bionik Laboratories Corp.

Market Cap 12 10.35 9.75 8.89 16.61 1.13K 16.73 115.46 44.81 579.57 45.06 44.08 1.9K P/E 2022
-0.21x
P/E 2023 -0.56x
Enterprise Value 1.98M 1.71M 1.61M 1.47M 2.75M 188M 2.77M 19.1M 7.41M 95.87M 7.45M 7.29M 315M EV / Sales 2022
0.17x
EV / Sales 2023 2.65x
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
1 day-99.90%
6 months+9,900.00%
Current year+9,900.00%
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.5
5 years 0
Extreme 1.0E-6
2.9
10 years 0
Extreme 0
222.02
Manager TitleAgeSince
Chief Executive Officer 46 14/07/2021
Director TitleAgeSince
Director/Board Member 35 18/03/2019
Director/Board Member 70 01/09/2017
Director/Board Member 46 13/10/2022
Date Insider Type Main position Quantity % Market Cap. Importance
13/06/23 Conversion

Chairman

186,112 1.4416%
13/06/23 Conversion

Director

3,102,878 24.0337%
09/06/23 Buy

Director

180,555 1.3985%
Change 5-day change 1-year change 3-year change Capi.($)
-99.90%-.--%-.--%-99.96% 1.26K
+0.30%-3.44%+25.68%+12.36% 225B
-0.70%-3.71%+4.13%-20.38% 148B
-1.19%-0.35%-17.09%+18.88% 131B
-2.31%+1.05%-56.14%-11.52% 70.1B
-1.18%-0.53%+10.16%+17.77% 52.35B
-1.58%-1.50%-17.12%-15.14% 50.91B
-1.22%-5.27%+19.29%+25.81% 42.68B
-0.46%-2.68%+41.34%+48.35% 40.5B
-0.97%-3.53%-15.52%+47.79% 33.3B
Average -10.93%-1.39%-0.53%+2.40% 79.38B
Weighted average by Cap. -0.77%-2.12%+2.33%+7.88%

Financials

2022 2023
Net sales 1.27M 1.1M 1.04M 943K 1.76M 120M 1.78M 12.25M 4.76M 61.52M 4.78M 4.68M 202M 1.81M 1.56M 1.47M 1.34M 2.5M 171M 2.52M 17.37M 6.74M 87.19M 6.78M 6.63M 286M
Net income -10.41M -8.98M -8.46M -7.71M -14.4M -983M -14.51M -100M -38.86M -503M -39.08M -38.23M -1.65B -4.95M -4.27M -4.02M -3.66M -6.85M -467M -6.9M -47.59M -18.47M -239M -18.57M -18.17M -785M
Net Debt -1.99M -1.72M -1.62M -1.47M -2.76M -188M -2.78M -19.16M -7.44M -96.18M -7.48M -7.31M -316M 1.98M 1.71M 1.61M 1.47M 2.75M 188M 2.77M 19.1M 7.41M 95.87M 7.45M 7.29M 315M
Logo Bionik Laboratories Corp.
Bionik Laboratories Corp. is a healthcare company focused on supplying solutions to those with movement impairments. Its product portfolio includes three InMotion Robots for rehabilitation following stroke and other neurological conditions and four products in varying stages of development. The InMotion robots offer patient-adaptive therapy, intended to restore upper-extremity motor control for a range of neurological conditions and recovery stages, including early recovery from acute stroke. InMotion Robots also provide objective evaluation assessments intended to measure and report the patient’s level of motor impairment and progress during therapy. Its solutions include InMotion Therapy, InMotion ARM, InMotion ARM/HAND, InMotion EVAL, InMotion Connect, InMotion for Physical Therapy, and InMotion for Occupational Therapy. InMotion Robotics provides the occupational therapist with a range of useful protocols designed to reduce many types of upper extremity neurological impairments.
Employees
-
  1. Stock Market
  2. Stocks
  3. BNKL Stock